NO20044208L - Kombinasjoner som omfatter epotilonderivater og alkyleringsmidler - Google Patents

Kombinasjoner som omfatter epotilonderivater og alkyleringsmidler

Info

Publication number
NO20044208L
NO20044208L NO20044208A NO20044208A NO20044208L NO 20044208 L NO20044208 L NO 20044208L NO 20044208 A NO20044208 A NO 20044208A NO 20044208 A NO20044208 A NO 20044208A NO 20044208 L NO20044208 L NO 20044208L
Authority
NO
Norway
Prior art keywords
combinations
alkylating agents
epothilone derivatives
hydrogen
lower alkyl
Prior art date
Application number
NO20044208A
Other languages
English (en)
Norwegian (no)
Other versions
NO20044208D0 (no
Inventor
John David Rothermel
Judith Rose Anderson
Paul M J Sheehy
Alan Boddy
Original Assignee
Univ Newcastle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Newcastle filed Critical Univ Newcastle
Publication of NO20044208D0 publication Critical patent/NO20044208D0/no
Publication of NO20044208L publication Critical patent/NO20044208L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicon Polymers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20044208A 2002-03-08 2004-10-04 Kombinasjoner som omfatter epotilonderivater og alkyleringsmidler NO20044208L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36273802P 2002-03-08 2002-03-08
PCT/EP2003/002364 WO2003075899A2 (en) 2002-03-08 2003-03-07 Combinations comprising epothilone derivatives and alkylating agents

Publications (2)

Publication Number Publication Date
NO20044208D0 NO20044208D0 (no) 2004-10-04
NO20044208L true NO20044208L (no) 2004-10-14

Family

ID=27805222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044208A NO20044208L (no) 2002-03-08 2004-10-04 Kombinasjoner som omfatter epotilonderivater og alkyleringsmidler

Country Status (23)

Country Link
EP (1) EP1485090B1 (ru)
JP (1) JP2005522461A (ru)
KR (1) KR20040101274A (ru)
CN (2) CN100402029C (ru)
AT (1) ATE375157T1 (ru)
AU (1) AU2003223958B2 (ru)
BR (1) BR0308258A (ru)
CA (1) CA2478223C (ru)
CY (1) CY1107126T1 (ru)
DE (1) DE60316775T2 (ru)
DK (1) DK1485090T3 (ru)
ES (1) ES2295575T3 (ru)
HK (1) HK1072723A1 (ru)
HU (1) HUP0500092A2 (ru)
IL (3) IL163774A0 (ru)
MX (1) MXPA04008707A (ru)
NO (1) NO20044208L (ru)
NZ (1) NZ535081A (ru)
PL (1) PL371098A1 (ru)
PT (1) PT1485090E (ru)
RU (1) RU2341260C2 (ru)
WO (1) WO2003075899A2 (ru)
ZA (1) ZA200406790B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2148676T3 (pl) * 2007-04-25 2016-12-30 Stosowanie sapacytabiny do leczenia choroby proliferacyjnej
EP3566719A1 (en) 2010-05-18 2019-11-13 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
WO1999042578A2 (en) * 1998-01-30 1999-08-26 Cold Spring Harbor Laboratory Modulation of cell proliferation, methods and reagents
MXPA01008374A (es) * 1999-02-22 2003-06-06 Squibb Bristol Myers Co Epotilonas c-21 modificadas.
UA75365C2 (en) * 2000-08-16 2006-04-17 Bristol Myers Squibb Co Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon

Also Published As

Publication number Publication date
PT1485090E (pt) 2008-01-14
AU2003223958A1 (en) 2003-09-22
ZA200406790B (en) 2006-05-31
WO2003075899A3 (en) 2004-03-11
CN100402029C (zh) 2008-07-16
IL163774A0 (en) 2005-12-18
ATE375157T1 (de) 2007-10-15
AU2003223958B2 (en) 2007-04-19
CN1939299A (zh) 2007-04-04
NZ535081A (en) 2007-05-31
CA2478223A1 (en) 2003-09-18
BR0308258A (pt) 2005-01-04
WO2003075899A2 (en) 2003-09-18
DE60316775D1 (de) 2007-11-22
JP2005522461A (ja) 2005-07-28
PL371098A1 (en) 2005-06-13
DE60316775T2 (de) 2008-04-30
ES2295575T3 (es) 2008-04-16
KR20040101274A (ko) 2004-12-02
EP1485090A2 (en) 2004-12-15
RU2004130283A (ru) 2005-08-10
IL188859A0 (en) 2008-04-13
CN1638767A (zh) 2005-07-13
HUP0500092A2 (hu) 2005-04-28
NO20044208D0 (no) 2004-10-04
HK1072723A1 (en) 2005-09-09
EP1485090B1 (en) 2007-10-10
IL163774A (en) 2010-12-30
DK1485090T3 (da) 2008-02-04
CA2478223C (en) 2012-05-15
CY1107126T1 (el) 2012-10-24
RU2341260C2 (ru) 2008-12-20
MXPA04008707A (es) 2006-03-08

Similar Documents

Publication Publication Date Title
ATE302775T1 (de) Carbolinderivate
AP1699A (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
DE60239679D1 (de) Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
ATE346067T1 (de) Carbolinderivate
IL174210A0 (en) 1,4 disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
NO20022528L (no) Kjemiske derivater og deres anvendelse som anti- telomerasemiddel
WO2004014869A3 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20044526L (no) Hemisterlinderivater og anvendelser derav
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
BR0305708A (pt) Derivados de benzimidazol para o tratamento de disfunção sexual
MXPA04003766A (es) Derivados de 2-amino-4-heteroariletil tiazolina y su utilizacion como inhibidores de no sintasa inducible.
MY148416A (en) Amine salt of carbostyril derivative
IL188859A0 (en) Combinations comprising epothilone derivatives and alkylating agents
DK1578741T3 (da) Aromatiske forbindelser som anti-inflammatoriske, immunmodulatoriske og anti-proliferative midler
MXPA03004023A (es) Compuestos quimicos.
DE60213798D1 (de) Carbolinderivate als pdev inhibitoren
NO20054289D0 (no) Imiciazo[4,5-b]kinolinderivater og dem anvendelse som NO-syntaseinhibitorer
EP1854464A3 (en) Combinations comprising epothilone derivatives and alkylating agents
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
EP1626044A4 (en) NEW PIPERIDINE DERIVATIVE
TH77907A (th) การบำบัดของโรคการงอกขยายด้วยอนุพันธ์อีพอธิโลน และการฉายรังสี
NO20082412L (no) Kinaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application